COMMUNIQUÉS West-GlobeNewswire

Alkeus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
07/01/2025
CAMBRIDGE, Mass., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to preserving the sight of individuals impacted by retinal diseases, today announced that Michel [...]
AI in Healthcare: Light-it and Puppeteer Set a New Standard for Patient Care and Efficiency
07/01/2025
Light-it, a leading digital health company, introduces Puppeteer, an AI-powered platform poised to redefine the patient-provider relationship. See how it's transforming how providers and patients connect, communicate, [...]
AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering
07/01/2025
IRVINE, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. (NYSE: AEON) (the “Company”), a clinical-stage biopharmaceutical company focused on developing a botulinum toxin complex under a 351(k) biosimilar [...]
Immix Biopharma Accelerates Enrollment in U.S. AL Amyloidosis Trial of NXC-201 CAR-T
07/01/2025
Successfully dosed 6 patients in safety run-in segment, now accelerating enrollment Positive data from first four patients announced December 2024 NXC-201 is the only one-time CAR-T therapy in development for AL [...]
Clearmind Medicine Announces Shareholders Meeting Results
07/01/2025
Vancouver, Canada, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the “Company”), a clinical-stage biotech company focused on discovery and development of novel [...]
FOXO TECHNOLOGIES INC.’S BOARD OF DIRECTORS ANNOUNCES SPECIAL MEETING OF SHAREHOLDERS
07/01/2025
MINNEAPOLIS, MN, Jan. 07, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”), will hold a special meeting of its shareholders at 10.30am EST on Friday, January 17, 2025. The [...]
Renovaro Appoints Nathen Fuentes as Chief Financial Officer
07/01/2025
Senior Biotechnology and Specialty Healthcare Financial Executive Brings Extensive Experience in Leading Acquisition and Organic Growth Initiatives LOS ANGELES, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: [...]
Anaptys to Present at the 43rd Annual J.P. Morgan Healthcare Conference
07/01/2025
SAN DIEGO, Jan. 07, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president [...]
Renovaro Issues Shareholder Letter and Provides Corporate Update
07/01/2025
Company to Host International Roadshow the Week of January 13, 2025 LOS ANGELES, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB) , a pioneer in cancer diagnostics and therapeutics powered by artificial [...]
Healthcare Integrated Technologies welcomes Justin Freishtat as its Chief Capital Officer
07/01/2025
Knoxville, TN, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Healthcare Integrated Technologies (OTC PINK: HITC), a global leader in AI-driven safety and monitoring solutions, proudly announces the appointment of Justin Freishtat [...]
QualityStar Expands Global Reach with Premium, Physician-Founded Supplements Tailored for Every Lifestyle
07/01/2025
QualityStar, a physician-founded supplement company, is expanding globally with multi-benefit products designed to simplify wellness. By combining scientifically backed ingredients into single, comprehensive formulas, [...]
Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare Conference
06/01/2025
CHASKA, Minn., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR ) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company [...]
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
06/01/2025
DUBLIN, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to transform lives, today announced that the Compensation Committee of Avadel’s Board of [...]
Revolution Medicines to Present at 43rd Annual J.P. Morgan Healthcare Conference
06/01/2025
REDWOOD CITY, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing novel targeted therapies for patients with RAS-addicted cancers, today [...]
ResMed Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference
06/01/2025
SAN DIEGO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Dr. Carlos Nunez, chief medical officer, will present at the 43rd Annual [...]
CytomX Therapeutics Announces 2025 Strategic Pipeline Priorities and Provides Corporate Update
06/01/2025
- Encouraging progress supports near-term focus on lead wholly-owned program, CX-2051 (EpCAM PROBODY ® ADC). Initial Phase 1a clinical data in advanced metastatic colorectal cancer (CRC) are anticipated in the first [...]
Oncocyte Expands Market Opportunity for VitaGraft™ Kidney
06/01/2025
Medicare coverage expanded following study showing that monitoring with Oncocyte’s assay significantly reduces time to rejection diagnosis in patients with newly developed donor-specific antibodies (DSA) MolDX confirms [...]
Kiniksa Pharmaceuticals to Present at 43rd Annual J.P. Morgan Healthcare Conference
06/01/2025
LONDON, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) today announced that it will present at the 43 rd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2025 [...]
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
06/01/2025
WESTLAKE VILLAGE, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, [...]

Pages